approved

Приложение 4 на ПЛС актуализация 02.09.2016

Unique identificator:  0fe19a2f-8a44-4ec9-9767-4176041b1c2e

здравеопазване лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2016-09-20 09:48:55
  • Created by: georgi_sivchev
  • Updated at: 2018-10-16 08:29:13
  • Updated by: migrate_data
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Vildagliptin EU/1/07/414/003 Galvus, Tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство Novartis Pharma GmbH, Германия 41.07 8.21 49.28 4% 1.64 42.71 8.54 51.25 16% 6.57 49.28 9.86 59.14 КЦ-912/26.05.2009 19.06.2009 Неактивен 2855
Immunoglobuline, normal human for extravascular adm. 20100812 GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 Octapharma (IP) Ltd., Обединено Кралство Octapharma AB SE -112 75 Stockholm Sweden 254.26 50.85 305.11 4% 10 264.26 52.85 317.11 16% 25 289.26 57.85 347.11 НСР-1311/03.10.2013 21.10.2013 Активен 2158
Immunoglobuline, normal human for extravascular adm. 20100812 GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 Octapharma (IP) Ltd., Обединено Кралство Octapharma AB SE -112 75 Stockholm Sweden 277.57 55.51 333.08 4% 10 287.57 57.51 345.08 16% 25 312.57 62.51 375.08 КЦРР-1778/06.12.2012 ; КЦРР-1862/15.12.2012 19.12.2012 Неактивен 2158
Immunoglobuline, normal human for extravascular adm. 20100812 GAMMANORM, Solution for injection, 165 mg/ml - 10 ml, mg, Pack: 1 Octapharma (IP) Ltd., Обединено Кралство Octapharma AB SE -112 75 Stockholm Sweden 119.31 23.86 143.17 4% 4.77 124.08 24.82 148.9 16% 19.09 143.17 28.63 171.8 КЦРР-1778/06.12.2012 ; КЦРР-1862/15.12.2012 ;НСР-146/07.06.2013 19.12.2012 Активен 1471
Immunoglobuline, normal human for extravascular adm. № ІІ-11489/08.12.2010 GAMMANORM, Solution for injection, 165 mg/ml - 10 ml, mg, Pack: 1 Octapharma (IP) Ltd., Обединено Кралство Octapharma AB, Stockholm, Швеция 145.22 29.04 174.26 4% 5.81 151.03 30.21 181.24 16% 23.24 174.27 34.85 209.12 КЦ-2489/26.07.2011 10.08.2011 Неактивен 1471
Immunoglobuline, normal human for extravascular adm. № ІІ-11489/08.12.2010 GAMMANORM, Solution for injection, 165 mg/ml - 20 ml, mg, Pack: 1 Octapharma (IP) Ltd., Обединено Кралство Octapharma AB, Stockholm, Швеция 290.44 58.09 348.53 4% 10 300.44 60.09 360.53 16% 25 325.44 65.09 390.53 КЦ-2487/26.07.2011 10.08.2011 Неактивен 2158
Bimatoprost, Timolol EU/1/06/340/001 GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 Allergan Pharmaceuticals, Ирландия Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия 22.34 4.47 26.81 6% 1.34 23.68 4.74 28.42 18% 4.02 27.7 5.54 33.24 НСР-5973/01.04.2015. 16.04.2015 Неактивен 3725
Bimatoprost, Timolol EMEA/H/C/668/001 GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 Allergan Pharmaceuticals, Ирландия Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия 23.06 4.61 27.67 6% 1.38 24.44 4.89 29.33 18% 4.15 28.59 5.72 34.31 НСР-1933/27.11.2013 20.02.2014 Неактивен 3725
Bimatoprost, Timolol EMEA/H/C/668/001 GANFORT, Eye drops, solution, 0.3 mg/ml + 5 mg/ml, mg, Pack: 3 ml x 1 Allergan Pharmaceuticals, Ирландия Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия 24.04 4.81 28.85 6% 1.44 25.48 5.1 30.58 18% 4.33 29.81 5.96 35.77 КЦРР-2316/20.02.2013 12.03.2013 Неактивен 3725
Succinylated Gelatine, Sodium Chloride II-0626/18.09.2007 Gelofusine 4%, Solution for infusion, 500 ml, -, Pack: 10 bottles Ecoflack plus B. Braun Melsungen AG, Германия B.Braun Melsungen AG, Carl Braun Str.1, Melsungen Germany 54.22 10.84 65.06 4% 2.17 56.39 11.28 67.67 16% 8.68 65.07 13.01 78.08 КЦ-346/17.12.2008 26.01.2009 Активен 335
Timolol 20100276/ 27.04.2010 Geltim, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 Laboratoires Thea, Франция Laboratoire Unither, France 7.9 1.58 9.48 7% 0.55 8.45 1.69 10.14 20% 1.58 10.03 2.01 12.04 протокол № 172/04.05.2016 НСР-3686/06.06.2014 23.06.2014 Активен 2897
Timolol 20100276/ 27.04.2010 Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 Laboratoires Thea, Франция Laboratoire Unither, France 7.9 1.58 9.48 7% 0.55 8.45 1.69 10.14 20% 1.58 10.03 2.01 12.04 НСР-3686/06.06.2014 23.06.2014 Неактивен 2897
Timolol 20100276/ 27.04.2010 Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 Laboratoires Thea, Франция Laboratoire Unither, France 9.52 1.9 11.42 7% 0.67 10.19 2.04 12.23 20% 1.9 12.09 2.42 14.51 НСР-1335/07.10.2013 29.10.2013 Неактивен 2897
Timolol 20100276/ 27.04.2010 Geltim Eye, Eye gel, 1mg/g in single dose container - 0,4 g, mg, Pack: 30 Laboratoires Thea, Франция Laboratoire Unither, France 10.01 2 12.01 6% 0.6 10.61 2.12 12.73 18% 1.8 12.41 2.48 14.89 КЦРР-1757/04.12.2012 г 17.01.2013 Неактивен 2897
Gemcitabine 20100752/23.11.2010 Gembin, Concentrate for solution for infusion, 40 mg/ml - 25 ml, mg, Pack: 1 Actavis Group PTC ehf., Исландия S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A.-Nerviano Plant, Италия 77.53 15.51 93.04 4% 3.1 80.63 16.13 96.76 16% 12.4 93.03 18.61 111.64 КЦРР-2114/28.01.2013 г 14.02.2013 Активен 1577
Gemcitabine 20100752/23.11.2010 Gembin, Concentrate for solution for infusion, 40 mg/ml - 5 ml, mg, Pack: 1 Actavis Group PTC ehf., Исландия S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A.-Nerviano Plant, Италия 16.72 3.34 20.06 6% 1 17.72 3.54 21.26 18% 3.01 20.73 4.15 24.88 КЦРР-2114/28.01.2013 г 14.02.2013 Активен 1576
Gemcitabine 20100377/25.01.2011 GEMCIT, Powder for solution for infusion, 38 mg/ml 2 000 mg, 100 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschaft fur klinische Spezialpraparate mbH, Fehlandtstr. 3, 20354 Hamburg, Германия; Fresenius Kabi Oncology Plc. Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, Обединено кралство 126.15 25.23 151.38 4% 5.05 131.2 26.24 157.44 16% 20.18 151.38 30.28 181.66 НСР-7523/19.11.2015. 05.12.2015 Активен 1921
Gemcitabine 20100377/ 15.06.2010 GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK 56.48 11.3 67.78 4% 2.26 58.74 11.75 70.49 16% 9.04 67.78 13.56 81.34 НСР-6534/24.06.2015 10.07.2015 Активен 2699
Gemcitabine 20100377 GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство 14.45 2.89 17.34 6% 0.87 15.32 3.06 18.38 18% 2.6 17.92 3.58 21.5 НСР-3787/16.06.2014 01.07.2014 Активен 2943
Gemcitabine 20100377/ 15.06.2010 GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK 75.67 15.13 90.8 4% 3.03 78.7 15.74 94.44 16% 12.11 90.81 18.16 108.97 НСР-3183/07.04.2014 23.04.2014 Неактивен 2699
Gemcitabine 20100377/25.01.2011 GEMCIT, Powder for solution for infusion, 38 mg/ml 2 000 mg, 100 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschaft fur klinische Spezialpraparate mbH, Fehlandtstr. 3, 20354 Hamburg, Германия; Fresenius Kabi Oncology Plc. Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, Обединено кралство 155.55 31.11 186.66 4% 6.22 161.77 32.35 194.12 16% 24.89 186.66 37.33 223.99 HCР-486/11.07.2013. 29.07.2013 Неактивен 1921
Gemcitabine 20100377 GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство 16.64 3.33 19.97 6% 1 17.64 3.53 21.17 18% 3 20.64 4.13 24.77 КЦРР-2723/20.03.2013 19.04.2013 Неактивен 2943
Gemcitabine 20100377/ 15.06.2010 GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesllschaft fur klinische Spezialpraparate GmbH, Fehlandstr. 3, 20354 Hamburg, Germany; 2. Fresenius Kabi Oncology Plc., Lion Court, Farnham Road, Bordon Hampshire GU35 ONF, UK 75.69 15.14 90.83 4% 3.03 78.72 15.74 94.46 16% 12.11 90.83 18.17 109 КЦРР-2112/28.01.2013 г 12.02.2013 Неактивен 2699
Gemcitabine II-9964/ 15.06.2010 GEMCIT, Powder for solution for infusion, 38 mg/ml, 1000 mg/vial, 50 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство 135.44 27.09 162.53 4% 5.42 140.86 28.17 169.03 16% 21.67 162.53 32.51 195.04 КЦ-2182/04.05.2011 18.05.2011 Неактивен 2699
Gemcitabine II-9964/ 15.06.2010 GEMCIT, Powder for solution for infusion, 38 mg/ml, 200 mg/vial, 10 ml, mg, Pack: 1 Фрезениус Каби България ЕООД, България Medac Gesellschalft fur klinishe Spezialpraparate GmbH, Fehlandtstr.3, 20354 Hamburg, Germany; Fresenius Kabi Oncology Plc, Обединено Кралство 27.09 5.42 32.51 6% 1.63 28.72 5.74 34.46 18% 4.88 33.6 6.72 40.32 издадена корекционна КЦ-2181/04.05.2011 КЦ-2182/04.05.2011 18.05.2011 Неактивен 2943
Showing 3051 to 3076 of 9175 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте